OpenAlex
PricingAboutJobs
Log inGet started
Work

Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment

HTML

Year: 2010
Type: article
Source: Neurobiology of Aging
DOI: 10.1016/j.neurobiolaging.2010.04.036
Authors: M. Lorenzi, M. Donohue, D. Paternicò, C. Scarpazza, S. Ostrowitzki, O. Blin, E. Irving, G.B. Frisoni
Institutions: Centro San Giovanni di Dio Fatebenefratelli, University of California San Diego, F. Hoffmann-La Roche AG, Centre National de la Recherche Scientifique, Institut de Neurosciences de la Timone, Hôpital de la Timone, GlaxoSmithKline (United Kingdom)
Language: English

Topic: Dementia and Cognitive Impairment Research
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: trial enrichment, biomarkers, Alzheimer's disease, mild cognitive impairment, disease-modifying drugs, sample size, hippocampal atrophy, FDG-PET, cerebrospinal fluid biomarkers, amyloid PET, [11C]PIB, amyloid-beta 42, tau protein, phosphorylated tau, ADNI
SDG: Good health and well-being

Open Access status: closed

Funders: Foundation for the National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering
OpenAlex ID: W2132481949
FWCI: 4.43
Cites: 29
Cited by: 57
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security